We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:UTHR
​
​
logo

United Therapeutics Corporation (UTHR)

Nasdaq • UTHR • US91307C1027

591.17Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 29, 2026, ORTEX estimated 6.4% of free float sold short, 3.4 days to cover, cost to borrow 0.39%. Sign up for live short interest data.

Market Cap

25.2b USD | # 835 in US

Volume

703.63k shares | 377.29m USD

Shares Outstanding

42.59m

Free Float Shares

91.36% | 38.91m

DB:UTH|
XTRA:UTH|
BOVESPA:U2TH34

News

UTHR key data

United Therapeutics Corporation (Nasdaq: UTHR) has a market capitalization of $25.18B. Last close $591.17 (as of 2026-11-16); 52-week range $455.63 to $614.23. ORTEX data as of 2026-10-29: short interest was 6.38% of free float, 3.4 days to cover and the average cost to borrow was 0.39%. Sign up for live short interest data.

Latest on UTHR

  • Nov 1, 2026UTHR: Short Covering Holds, Options Lean Bullish Before Wednesday's Print
All UTHR news on ORTEX News
  • UTHR news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.